Fresenius
FSNUY12.8800.85% ( -0.110 )
Fresenius (FSNUY)
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medica...
- Open
- 12.980
- High
- 12.980
- Low
- 12.860
- Prev. Close
- 12.990
- Volume
- 57.50K
- Turnover
- 743.40K
- Avg Price
- 12.930
- Bid/Ask Ratio
- --
- Amplitude
- 0.92%
- 52wk High
- 33.020
- Volume Ratio
- 0.20
- Turnover Ratio
- 0.00%
Fresenius Analyst Rating
View MoreForecast & Rating
Jul 30, 2026Price forecast
$15.8122.75%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 20 hours ago
Fresenius Kabi vedolizumab biosimilar PB016 accepted for FDA, EMA review
- PUBT · Jul 23 at 03:03 AM
Fresenius names Thomas Thestrup head of new Ventures unit
- StockTitan · Jul 22 at 08:15 PM
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation | FSNUY Stock News
- PUBT · Jul 15 at 03:21 AM
Fresenius to publish Q2 2026 financial results
- Tip Ranks · Jul 13 at 04:45 AM
Jefferies Keeps Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
- PUBT · Jul 13 at 12:06 AM
Fresenius keeps 2026 outlook unchanged after German health insurance contribution law passed
